Jubilant Pharmova reported a 14% revenue jump to ₹8,279.6 crore for FY26, driven by its CDMO Sterile Injectables and Generics segments. The company recommended a ₹5 per share dividend, but EBITDA margins faced pressure from facility issues.
Read More
Kilitch Drugs India reported an 18.7% rise in FY26 revenue to ₹235.47 crore and an 18.3% increase in net profit to ₹29.50 crore. The company also commissioned a new manufacturing facility in Maharashtra, designed to meet global regulator...
Read More
Aarti Drugs reported a 19% year-on-year increase in revenue to ₹703.6 crore for Q1 FY27. EBITDA grew 30% to ₹96.9 crore with margins expanding. However, Profit After Tax saw a 7% decline to ₹50.1 crore, partly due to a one-time tax refun...
Read More
Zydus Lifesciences' injectable facility in Ahmedabad received a Voluntary Action Indicated (VAI) classification from the USFDA. This means the US FDA found areas for improvement but isn't recommending enforcement action, providing regula...
Read More
Hester Biosciences reported strong standalone growth with revenue up 14% and PAT up 88% YoY, driven by its Poultry Healthcare division. However, consolidated revenue declined 8% due to international issues.
Read More
Apollo Hospitals reported strong FY26 results with consolidated revenue rising 16% to ₹25,228.5 crore and PAT growing 33% to ₹2,002.7 crore. The company also proposed demerging its digital and pharmacy businesses.
Read More
Divis Laboratories posted robust Q1 FY27 results, with consolidated revenue at ₹3,080 crore and profit at ₹902 crore, a 65% year-over-year increase. The company also appointed two senior management personnel for procurement.
Read More
Dr Reddy's Laboratories announced U.S. FDA approval for its rituximab biosimilar, a drug for treating certain cancers and autoimmune diseases. The company partnered with Fresenius Kabi for U.S. commercialization. This validates their com...
Read More
Neuland Laboratories announced the start of commercial production at expanded facilities in two Telangana units. This marks a key operational milestone, enabling increased manufacturing output.
Read More